Clinical Effectiveness and Impact on Health-related Quality of Life in Peruvian Patients With Psoriasis After 16 Weeks of Adalimumab Therapy
Stopped This study was prematurely terminated due to low enrollment and not for safety reasons.
Conditions
- Moderate to Severe Psoriasis
Sponsor
AbbVie (prior sponsor, Abbott)